Targeting circRNA TFRC in bladder cancer alleviates urinary tract infections by reducing erythroid progenitor cells
Ontology highlight
ABSTRACT: the same population of EPCs was detected in bladder cancer patients. The EPCs, whose function could be reversed via anti-CD71 treatment, were induced by the circRNA TFRC (circular RNA derived from the transferrin receptor mRNA; cTFRC) in bladder cancer exosomes.
ORGANISM(S): Mus musculus
PROVIDER: GSE171000 | GEO | 2021/09/27
REPOSITORIES: GEO
ACCESS DATA